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ABSTRACT CarD is an essential RNA polymerase (RNAP) interacting protein in Myco-
bacterium tuberculosis that stimulates formation of RNAP-promoter open complexes.
CarD plays a complex role in M. tuberculosis growth and virulence that is not fully
understood. Therefore, to gain further insight into the role of CarD in M. tuberculosis
growth and virulence, we determined the effect of increasing the afﬁnity of CarD for
RNAP. Using site-directed mutagenesis guided by crystal structures of CarD bound
to RNAP, we identiﬁed amino acid substitutions that increase the afﬁnity of CarD for
RNAP. Using these substitutions, we show that increasing the afﬁnity of CarD for
RNAP increases the stability of the CarD protein in M. tuberculosis. In addition, we
show that increasing the afﬁnity of CarD for RNAP increases the growth rate in M.
tuberculosis without affecting 16S rRNA levels. We further show that increasing the
afﬁnity of CarD for RNAP reduces M. tuberculosis virulence in a mouse model of in-
fection despite the improved growth rate in vitro. Our ﬁndings suggest that the
CarD-RNAP interaction protects CarD from proteolytic degradation in M. tuberculosis,
establish that growth rate and rRNA levels can be uncoupled in M. tuberculosis and
demonstrate that the strength of the CarD-RNAP interaction has been ﬁnely tuned
to optimize virulence.
IMPORTANCE Mycobacterium tuberculosis, the causative agent of tuberculosis, re-
mains a major global health problem. In order to develop new strategies to battle
this pathogen, we must gain a better understanding of the molecular processes in-
volved in its survival and pathogenesis. We have previously identiﬁed CarD as an es-
sential transcriptional regulator in mycobacteria. In this study, we detail the effects
of increasing the afﬁnity of CarD for RNAP on transcriptional regulation, CarD pro-
tein stability, and virulence. These studies expand our understanding of the global
transcription regulator CarD, provide insight into how CarD activity is regulated, and
broaden our understanding of prokaryotic transcription.
KEYWORDS Mycobacterium tuberculosis, RNA polymerase, protein stability, protein-
protein interactions, rRNA, transcription initiation factor
Mycobacterium tuberculosis remains a major global health problem, resulting in 9.6million new cases of tuberculosis (TB) in 2014 and 1.5 million TB-related deaths
that year (1). Control of the M. tuberculosis epidemic is hampered by the increasing
prevalence of multidrug-resistant strains, which resulted in 480,000 patients developing
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multidrug-resistant TB in 2014. In order to develop new strategies to battle this
pathogen, we must gain a better understanding of the molecular processes involved in
its survival and pathogenesis. Recent studies have identiﬁed numerous aspects of
mycobacterial physiology that differ from what has been identiﬁed in model organisms
and highlight the importance of research directly in mycobacteria to understand their
lineage speciﬁc physiology. We have identiﬁed CarD as an essential transcriptional
regulator in mycobacteria that is not conserved in the model organism Escherichia coli,
which has traditionally been used to study mechanisms of transcription (2). carD is
conserved in all mycobacteria and numerous other bacteria (2–5) but is not found in
eukaryotes. Therefore, studying CarD will broaden our understanding of prokaryotic
transcription while also characterizing a promising potential target for desperately
needed new therapeutic strategies for TB.
Chromatin immunoprecipitation-sequencing (ChIP-seq) experiments in mycobacte-
ria demonstrated that CarD is localized with RNA polymerase (RNAP) holoenzyme at
promoters throughout the genome, indicating that CarD is a global regulator of
transcription initiation (4). CarD interacts directly with the 1 lobe of the RNAP-
subunit through its N-terminal RNAP interaction domain (RID) (2, 5, 6) and with DNA
just upstream of the 10 element of the promoter through a conserved basic patch in
its C-terminal domain (3, 4, 7). Within the basic patch, studies have identiﬁed a highly
conserved tryptophan residue that is proposed to wedge into the minor groove at the
upstream edge of the transcription bubble (3, 4). Thus far, CarD’s activity has primarily
been studied on rRNA promoters. Using in vitro transcription assays, we have shown
that CarD stabilizes RNAP-promoter open complexes at rRNA promoters during tran-
scription initiation and that CarD requires interactions with both RNAP and DNA, as well
as the activity of the conserved tryptophan to do so (4, 6–8). Recently, a bulk ﬂuores-
cence assay was used to measure the effect of CarD on the kinetics of transcription
initiation at the M. tuberculosis rRNA promoter rrnAP3. These studies revealed that,
compared to the Escherichia coli RNAP, the Mycobacterium bovis RNAP forms a signif-
icantly less stable open complex at rrnAP3 in the absence of CarD. Addition of CarD
stabilizes M. bovis RNAP-rrnAP3 open complexes by binding to the RNAP-promoter
open complex with high afﬁnity and preventing collapse to closed complex. With lower
afﬁnity, CarD also binds the RNAP-promoter closed complex and promotes melting of
the DNA to form open complex. Importantly, the cellular concentration of CarD in
wild-type (WT) M. tuberculosis is sufﬁcient for both of these activities to be physiolog-
ically relevant (8). Mycobacterial strains expressing mutants of CarD with weakened
afﬁnity for the RNAP- subunit, weakened afﬁnity for DNA, or that are mutated at the
conserved tryptophan all express lower levels of rRNA exhibit lower rRNA promoter
activation in promoter-lacZ fusion experiments, grow slower, and are more sensitive to
multiple stresses and antibiotics compared to strains expressing WT CarD (4, 6, 7).
In this study, we use CarD mutants with increased afﬁnity for RNAP to dissect the
role of CarD binding to RNAP in vitro and in vivo. We detail the distinct effects of
increasing the afﬁnity of CarD for RNAP on open complex stability, transcriptional
regulation, CarD protein stability, and the effects of these changes on growth and
virulence. These studies expand our understanding of the global transcription regulator
CarD and the impact of CarD activity on the physiology of M. tuberculosis, while also
providing insight into how CarD activity is regulated.
RESULTS
Identiﬁcation of amino acid substitutions in the N terminus of CarD that
increase the afﬁnity of CarD for RNAP-. To identify substitutions that strengthen the
M. tuberculosis CarD/RNAP- 1 lobe interaction, we used site-directed mutagenesis
guided by a comparison between our X-ray structure of Thermus thermophilus CarD in
complex with the 1 lobe of T. thermophilus RNAP (Protein Data Bank [PDB] accession
no. 4XAX) (3) (Fig. 1A), solved to 2.4-Å resolution, and the structure of M. tuberculosis
CarD in complex with the RNAP- 1 and 2 lobes of M. tuberculosis RNAP (PDB
accession no. 4KBM) (9), solved to 2.11 Å. The 1 lobes from each structure were
Garner et al. Journal of Bacteriology
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FIG 1 Single point mutations in CarD speciﬁcally increase CarD’s afﬁnity for RNAP-. (A) Crystal structure of T. thermophilus
CarD in complex with the 1 lobe of T. thermophilus RNAP reveals molecular interactions between the two proteins at
high-resolution (2.4-Å) detail. CTD, C-terminal domain. (B) Structural alignment of the 1 lobes of T. thermophilus
CarD:1-lobe and M. tuberculosis CarD:1-lobe structures to compare the interactions between the CarD RID and RNAP 1
in each organism. (C) Atom displacement was rendered visually using PyMOL B-factor rendering. The spectrum scale above
illustrates a range of low B-factors (highly ordered, blue indicates under 30%) to high B-factors (disordered, red indicates
90% or higher). (D) Alignment of T. thermophilus (top) and M. tuberculosis (bottom) CarD RIDs comparing interactions with
their cognate RNAP 1 lobe. Black shading indicates residues that are identical and yellow shading indicates residues that
are homologous. The following groups are considered homologous: R and K; E and D; V, I, L, M, and A; S and T; and Q and
N. Bullets are deﬁned in the ﬁgure by interactions unique to each organism or shared by both. The red box designates the
region that is observed in the T. thermophilus complex but not the M. tuberculosis complex. (E) Results of -Gal assays (6,
15) examining the effects of amino acid substitutions at position 27 of the M. tuberculosis CarD RID on the interaction
between the M. tuberculosis CarD RID and the M. tuberculosis 1 lobe. The bar graphs show -Gal activity in Miller units
observed in assays done using cells containing the indicated M. tuberculosis CarD RID derivative and the M. tuberculosis 1
lobe, as well as assays performed using cells containing only the M. tuberculosis 1 lobe. Each graph shows the means 
the SEM of data from ﬁve replicates. Statistical signiﬁcance was analyzed by analysis of variance (ANOVA) and Tukey’s
multiple-comparison test (n.s., not signiﬁcant; **, P  0.01; ****, P  0.0001). (F) Immunoprecipitation experiments with a
(Continued on next page)
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aligned over 919 atoms in PyMOL (version 1.8; Schrödinger, LLC) to give a root mean
square (RMS) of 1.095 Å, and the interactions between the 1 lobe and the CarD RID
were compared. Many of the interactions were conserved between the T. thermophilus
and M. tuberculosis structures (Fig. 1B and D), but a signiﬁcant difference was noted in
a region that included a loop at the tip of the RID (residues 26 to 29 in M. tuberculosis)
that was not modeled in the M. tuberculosis structure, presumably due to a lack of
density. Cartoon rendering by B-factors (PyMOL) of both structures revealed that this
loop was highly disordered in M. tuberculosis but well ordered in T. thermophilus,
presumably due to its interaction with the 1 lobe (Fig. 1C). In particular, the T.
thermophilus structure revealed a nonpolar interaction between loop residue V28 from
CarD (I27 in M. tuberculosis) and I101 and I108 from the 1 lobe (I140 and I147 in M.
tuberculosis) that was not visible in the M. tuberculosis structure due to disorder
(Fig. 1B). Based on the T. thermophilus structure of the 1 lobe in complex with CarD,
we predicted that the isoleucine side chain at position 27 of M. tuberculosis CarD likely
contributes to an interaction between the M. tuberculosis CarD RID and the M. tuber-
culosis 1 lobe that may not have been observed in the crystal structure due to crystal
packing constraints. Furthermore, structural modeling predicts that removal of the
isoleucine side chain at position 27 of the M. tuberculosis CarD RID would weaken the
interaction between the M. tuberculosis CarD RID and the M. tuberculosis 1 lobe,
whereas substitutions of position 27 with residues containing side chains that are more
hydrophobic than isoleucine might strengthen the interaction between the M. tuber-
culosis CarD RID and the M. tuberculosis 1 lobe.
To test these predictions, we used an E. coli-based bacterial two-hybrid assay that
detects the interaction between the M. tuberculosis CarD RID and the M. tuberculosis 1
lobe (6). In this assay, the interaction between the WT M. tuberculosis CarD RID (amino
acids 1 to 66) and the M. tuberculosis 1 lobe results in a 3-fold increase in
-galactosidase (-Gal) activity from the two-hybrid test promoter (Fig. 1E). Substitu-
tion of I27 of the CarD RID with alanine or glycine reduced the -Gal activity to near
background levels, while substitution of I27 of the CarD RID with the bulkier hydro-
phobic residues phenylalanine and tryptophan resulted in 7- and 9-fold increases,
respectively, in -Gal activity relative to that observed with the WT M. tuberculosis CarD
RID (Fig. 1E). The results of the two hybrid assays indicate that I27A and I27G substi-
tutions weaken the interaction between the M. tuberculosis CarD RID and the M.
tuberculosis 1 lobe whereas I27F and I27W substitutions strengthen the interaction
between the M. tuberculosis CarD RID and the M. tuberculosis 1 lobe, a ﬁnding
consistent with the predictions from the structural modeling.
To determine whether the CarD I27F and I27W mutations increase the afﬁnity of the
interaction between CarD and RNAP- subunit in vivo, we constructed Mycobacterium
smegmatis strains expressing hemagglutinin (HA)-tagged wild-type CarD (CarDWT),
CarD with an R-to-E change at position 25 (CarDR25E), CarDI27F, or CarDI27W. Coimmu-
noprecipitation experiments in M. smegmatis demonstrated that CarDI27W and CarDI27F
mutants coprecipitated more RNAP- than CarDWT (Fig. 1F). As previously reported, the
CarDR25E mutant, which has lower afﬁnity for RNAP- than CarDWT, coprecipitated less
RNAP- than CarDWT (6). The CarDI27W mutant associated with more RNAP- than
CarDI27F, indicating a higher-afﬁnity interaction.
CarDI27F and CarDI27W mutants stabilize open complexes at lower concentra-
tions than CarDWT. CarD regulates transcription initiation by binding to and stabilizing
RNAP-promoter open complexes (3, 4, 7, 8, 10). We have previously developed a
ﬂuorescence assay for CarD activity that reports on open complex formation in real-
time. In this assay, a Cy3 label, which exhibits a 2-fold ﬂuorescence enhancement in
open complex, is incorporated at the 2 position on the nontemplate strand of the M.
FIG 1 Legend (Continued)
monoclonal antibody speciﬁc for HA in the M. smegmatis carD attB::tet-carD strain expressing M. tuberculosis CarDWT-HA
(lane 1), CarDR25E-HA (lane 2), CarDI27F-HA (lane 3), or CarDI27W-HA (lane 4). Immunoprecipitated eluates were analyzed by
Western blotting with monoclonal antibodies speciﬁc for either RNAP- or CarD.
Garner et al. Journal of Bacteriology
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tuberculosis rrnAP3 promoter within a linear fragment of M. tuberculosis genomic DNA
containing nucleotides 1470151 to 1470300 (8). M. bovis RNAP-A holoenzyme with or
without M. tuberculosis CarD is then mixed with the labeled DNA fragment via stopped-
ﬂow spectrophotometry, and the ﬂuorescence is monitored for 20 min. The Cy3 label
increases ﬂuorescence in the open complex conformation, and thus the rate of open
complex formation can be monitored as a change in ﬂuorescence. The amplitude of the
ﬂuorescence intensity curve correlates to the equilibrium amount of open complex in
a given condition (8). To monitor the effect of increasing the afﬁnity of CarD for RNAP
on the formation and stability of open complexes, we performed this assay with
concentrations of CarDI27F and CarDI27W ranging for 0 to 1800 nM and ﬁxed concen-
trations of RNAP (225 nM) and promoter DNA (10 nM) (Fig. 2A). We found that the CarD
concentration necessary to reach half of the maximum level of open complex at
saturation (half-maximal concentration) was lower for CarDI27F (17  2 nM) and
CarDI27W (23  3 nM) than for CarDWT (59  10 nM), which is consistent with a higher
afﬁnity of the CarD I27 mutants for RNAP in initiation complexes compared to CarDWT
(Fig. 2A).
CarDI27F and CarDI27W mutants accelerate promoter opening at lower concen-
trations than CarDWT. We have previously reported modeling based on the trends of
the slowest observed rate in the real-time ﬂuorescent traces (kobs3) that suggests that
CarD stabilizes open complex through a two-tiered concentration-dependent mecha-
































































































FIG 2 Effects of increasing the afﬁnity of CarD for RNAP on open complex stability. (A) Equilibrium ﬂuorescence fold change
normalized to the fold change at high CarD concentrations (saturation) for each mutant of CarD with 225 nM M. bovis RNAP-A
and 10 nM Cy3-labeledM. tuberculosis rrnAP3 promoter. BothM. tuberculosis CarDI27F (red) and CarDI27W (blue) mutants achieve
a half-maximal effect (dashed line) at lower concentrations (17  2 nM for CarDI27F and 23  3 nM for CarDI27W) than M.
tuberculosis CarDWT (black; 59  10 nM). (B) kobs3 values, calculated using ProData Viewer software from Applied Photophysics,
of open complex formation as a function of CarD concentration for M. tuberculosis CarDWT (black), CarDI27F (red), and CarDI27W
(blue). (C) In vitro transcription assay results showing a representative gel and a graph of the ratio of the amount of 3-nt initial
transcript formed by 200 nM M. bovis RNAP-A from 10 nM a linear DNA fragment in the presence of 2 M CarD versus in the
absence of CarD for reaction mixtures containing no CarD, M. tuberculosis CarDWT, CarDR25E, CarDI27F, or CarDI27W. The graph
shows the means  the SEM of data from at least four replicates. Statistical signiﬁcance was analyzed by ANOVA and
Tukey’s multiple-comparison test (***, P  0.001; ****, P  0.0001).
Increasing CarD Afﬁnity for RNAP in Mycobacteria Journal of Bacteriology
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afﬁnities (8). More speciﬁcally, the model predicts that at low concentrations (i.e.,
100 nM), CarDWT binds to open complex and prevents bubble collapse, resulting in
more open complex and a slower observed rate. The model further predicts that at
higher concentrations, CarDWT binds to the closed complex and accelerates the rate of
opening, resulting in still more open complex and an acceleration in the observed rate.
Analysis of kobs3 as a function of CarD concentration was performed for the CarD I27
mutants as previously described (8) (Fig. 2B). We found that the I27 mutants begin to
accelerate kobs3 at lower concentrations (50 nM) than WT CarD (100 nM). In fact, for
CarDI27W we did not observe a deceleration in kobs3 even at the lowest concentration
tested (16 nM). The two-tiered kinetic model predicts that acceleration in kobs3 arises
from CarD binding to closed complex, which increases the rate of promoter opening.
Thus, our working model predicts that, even at 16 nM, CarDI27W is associating with
closed complex and accelerating opening. The acceleration of the observed rate at
lower concentrations coupled with the lower half-maximal concentration for open
complex stabilization is consistent with a model where the CarD I27 mutants have
higher afﬁnities to both closed and open RNAP-promoter complexes compared to
CarDWT.
Increasing the afﬁnity of CarD for RNAP increases formation of initial RNA
products. To investigate whether increasing the afﬁnity of CarD for RNAP affects RNA
synthesis, we monitored initial product formation in a multiround in vitro transcription
assay (10). M. bovis RNAP-A holoenzyme was incubated with the promoter template
used in the ﬂuorescence assays, but without the Cy3 label, in the presence or absence
of WT or mutant M. tuberculosis CarD. GpU dinucleotide was used as the initiating
nucleotide, and radiolabeled UTP was added as the extending nucleotide. Reaction
mixtures were incubated for 20 min, after which the amounts of initial trinucleotide
RNA products (GpUpU) were quantiﬁed. Addition of CarDWT protein increases the
amount of initial RNA product formation 6-fold compared to the amount of product
produced in the absence of CarD (Fig. 2C), whereas CarDR25E, which has decreased
afﬁnity for RNAP, only increases the amount of product formed 2-fold. In contrast,
CarDI27F and CarDI27W increase the amount of product formed 9-fold. These data
demonstrate that increasing the afﬁnity of CarD for the RNAP results in an increase in
initial RNA product formation. We infer that the effect of strengthening the interaction
between CarD and RNAP on initial RNA product formation is a consequence of an
increase in the formation of RNAP-promoter complexes (Fig. 2).
Increasing the afﬁnity of CarD for RNAP stabilizes the CarD protein in M.
tuberculosis. In previous work, we constructed a strain of M. tuberculosis in which a
copy of carD is expressed from a constitutive promoter at the attB site, a nonendog-
enous chromosomal locus, and the endogenous copy of carD is deleted (2). We have
previously shown that a strain of M. tuberculosis that expresses carDR47E, which encodes
a CarD protein that has an R-to-E change at position 47 and weakened afﬁnity for the
RNAP, from the attB site grows more slowly than a strain expressing wild-type carD
(carDWT) from the attB site (6). To determine the effects of increasing the afﬁnity of CarD
for RNAP in the bacteria, we constructed M. tuberculosis strains expressing carDI27F or
carDI27W from the attB site. We ﬁrst determined the expression levels of the carD alleles
in each strain by measuring carD transcript and protein levels. We found the CarDWT,
CarDI27F, CarDI27W, and CarDR47E strains all produce equal levels of carD transcript, as
expected given that the strains express the carD gene from the same promoter (Fig.
3A). However, when we examined the protein content in these strains we found that
the CarDI27F and CarDI27W strains reproducibly had more CarD protein than the CarDWT
strain (Fig. 3B, RNAP  levels also shown as a loading control). In addition, this effect is
proportional to the magnitude of the change in afﬁnity, since the CarDI27W strain
reproducibly has more CarD protein than the CarDI27F strain and the CarDWT strain has
more CarD protein than CarDR47E. Given the equal amount of transcript being pro-
duced, the different levels of protein indicate posttranslational differences in the
stability of CarD protein in these strains. CarD has previously been identiﬁed as a Clp
protease substrate in M. tuberculosis (11). Taken together, our data can be explained in
Garner et al. Journal of Bacteriology
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the context of a model where CarD is protected from proteolysis when associated with
RNAP.
Increasing CarD’s afﬁnity for RNAP increases the growth rate inM. tuberculosis.
We have previously reported that decreasing CarD’s afﬁnity for RNAP decreases growth
rate in M. tuberculosis strain (6). To determine the effect of increasing CarD’s afﬁnity for
RNAP on growth rate, we back-diluted cultures in the exponential growth phase (to
avoid an initial lag phase) into fresh liquid Sauton’s medium and monitored growth. We
found that the CarDI27F and CarDI27W strains had a faster doubling time than the
CarDWT stain (26.31-, 25.75-, and 30.74-h doubling times, respectively) (Fig. 3C and D).
These results, as well as the growth defect previously reported in a strain expressing a
CarD mutant with lower afﬁnity for RNAP (6), demonstrate that the afﬁnity of CarD for
the RNAP can impact growth rate in M. tuberculosis.
Increasing the afﬁnity of CarD for RNAP does not result in differences in rRNA
transcript levels in M. tuberculosis, despite the effects on growth rate. We have
previously shown that decreasing the afﬁnity of CarD for RNAP results in decreased
rRNA levels and slower growth (6, 7). Because rRNA levels are often correlated to
growth rate (12–14), the decreased rRNA levels in the CarD mutants with lower afﬁnity




























































































































































FIG 3 Increasing CarD’s afﬁnity for RNAP results in more stable CarD protein and faster growth without a change
in rRNA levels. (A) The ratio of carD transcript levels in exponential cultures of the carD attB::tet-carD strain
expressing CarDI27F, CarDI27W, or CarDR47E to levels in the CarDWT strain when grown in Sauton’s medium. Transcript
levels were determined using qRT-PCR and normalized to sigA. (B) Western blot analysis results of two biological
replicates of lysates from the same cultures as used in panel A. Membranes were blotted with a monoclonal
antibody against RNAP- (top) or a polyclonal antibody against CarD (bottom). RNAP- was used as a loading
control for each sample. (C) Representative growth curves of the carD attB::tet-carD strain expressing CarDWT,
CarDI27F, or CarDI27W in Sauton’s medium. (D) Doubling times of the carD attB::tet-carD strain expressing
CarDWT, CarDI27F, or CarDI27W in Sauton’s medium. Doubling times were calculated for each of ﬁve biological
replicate growth curves using the exponential growth equation and excluding values after the optical density at
600 nm (OD600) reached 1 to focus on the growth rate in the exponential growth phase. (E) Ratio of 16S rRNA levels
in exponential cultures of the carD attB::tet-carD strain expressing CarDI27F or CarDI27W to levels in the CarDWT
strain when grown in Sauton’s medium. Transcript levels were determined using qRT-PCR and normalized to sigA.
Each graph shows the means  the SEM of data from at least three replicates. Statistical signiﬁcance was analyzed
by ANOVA and Tukey’s multiple-comparison test (n.s., not signiﬁcant; *, P  0.05).
Increasing CarD Afﬁnity for RNAP in Mycobacteria Journal of Bacteriology
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determine the effect of increasing the afﬁnity of the interaction between CarD and
RNAP on rRNA levels in the bacterium, we isolated RNA from exponential cultures of
CarDWT, CarDI27F, and CarDI27W strains in Sauton’s medium and performed quantitative
real-time PCR (qRT-PCR) analysis for the levels of stable 16S rRNA using primers internal
to the 16S rRNA transcript (Fig. 3E). The CarD I27 mutants that have higher afﬁnity for
RNAP express the same amount of rRNA as the CarDWT strain, indicating that the faster
growth in these strains is not a result of increasing rRNA expression. Therefore, the rRNA
levels and growth rate are uncoupled in strains expressing CarD proteins with various
afﬁnities to RNAP. Thus, the effects of altering CarD’s afﬁnity for RNAP on growth rate
can occur independently of effects on rRNA levels. To the best of our knowledge, this
is also the ﬁrst report of rRNA levels and growth rate being uncoupled inM. tuberculosis.
Increasing the afﬁnity of CarD for RNAP attenuates survival of M. tuberculosis
during infection of mice. We have previously shown that weakening the interaction
of CarD with RNAP results in decreased bacterial survival by 35 days postinfection (dpi)
in mice (6). To determine the effect of increasing the afﬁnity of CarD for RNAP on
virulence, we infected C57BL/6J mice with the M. tuberculosis CarDWT, CarDI27F, or
CarDI27W strains and measured the bacterial burden in the lungs at 21 and 35 dpi (Fig.
4). Both the CarDI27F and the CarDI27W mutants were attenuated for survival in the mice
and displayed signiﬁcantly lower bacterial burden in the lungs (Fig. 4). Speciﬁcally, the
CarDI27W strain displayed signiﬁcantly lower bacterial burden than the CarDWT strain at
21 and 35 dpi, whereas the CarDI27F strain had lower bacterial burdens than CarDWT at
35 dpi. The severity of the virulence defect in the CarD mutants mirrors the effect of
these mutations on the afﬁnity of CarD for RNAP, with CarDI27W exhibiting both a
higher afﬁnity and a more pronounced virulence defect than CarDI27F. These data show
that although increasing the afﬁnity of CarD for RNAP increases the rate of formation
of transcription competent RNAP-promoter complexes and increases growth rates in
culture, it results in a loss of virulence. The degree of attenuation at 35 dpi for the CarD
I27 mutants is similar to that previously reported for M. tuberculosis strains expressing
a mutant CarD protein with lower afﬁnity for the RNAP (6). Thus, either decreasing or
increasing the afﬁnity of CarD for RNAP has a detrimental effect on the virulence of M.
tuberculosis. We therefore propose that this indicates that the afﬁnity of CarD for RNAP
is ﬁnely tuned to the physiology of this obligate pathogen to optimize virulence.
DISCUSSION
In this study, we investigated both the biochemical and the physiological effects of






































FIG 4 Increasing CarD’s afﬁnity for RNAP attenuates M. tuberculosis in a mouse model of infection. Dot
plot of CFU in the lungs of C57BL/6J mice infected with the carD attB::tet-carD strain expressing either
CarDWT (), CarDI27F (), or CarDI27W (Œ). Each time point is the means  the SEM of data from at least
six mice per strain. Statistical signiﬁcance was analyzed by ANOVA and Tukey’s multiple-comparison test
(**, P  0.01; ***; P  0.001). All comparisons were tested, and only signiﬁcantly different comparisons
are shown.
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regulation and the effect of increasing the afﬁnity of CarD for RNAP- on growth rate
and virulence.
Using a real-time ﬂuorescence assay, we found that increasing the afﬁnity of CarD
for RNAP leads to a decrease in the concentration of CarD required for half-maximal
open complex formation and stability (Fig. 2A). Our data further show that the higher-
afﬁnity CarD mutants result in increased stability of an RNAP-promoter complex and an
increase in the formation of initial RNA products (Fig. 2C). However, despite these
positive effects of the CarD I27 mutants on the formation of transcription competent
RNAP-promoter complexes at rrnAP3 in vitro, M. tuberculosis strains expressing CarDI27F
or CarDI27W did not contain higher levels of rRNA than the CarDWT strain (Fig. 3E). This
observation may be explained by the presence of other factors in vivo that impact
whether rRNA levels respond to changes in the afﬁnity of CarD for the RNAP. In
addition, increasing the afﬁnity of CarD for RNAP- may affect other stages of tran-
scription after open complex formation (i.e., promoter escape) that ultimately impact
full transcript production. These possibilities will be explored in future investigations.
We found that increasing the afﬁnity of CarD for RNAP results in an increase in
growth rate without changing the levels of rRNA (Fig. 3C and D). This suggests that in
WT strains rRNA and ribosomes would be in excess of the amounts required to
accommodate a higher growth rate. We also found that increasing the afﬁnity of CarD
for RNAP in M. tuberculosis results in attenuated virulence in mice (Fig. 4). Together,
these ﬁndings demonstrate that the differences in growth rate and virulence of the
CarD I27 mutant strains are not a result of altered rRNA content but are instead another
consequence of varied levels or activity of CarD proteins, thus uncoupling the role of
CarD in regulating rRNA content from its effect on growth rate. Therefore, the essential
function of CarD is unlikely to be limited to regulation of rRNA levels. These data also
indicate that there exist non-rRNA genes that are more sensitive to changes in the
afﬁnity of CarD for RNAP than the rRNA genes. We have previously shown that in the
absence of CarD, the mycobacterial RNAP is only weakly able to form open complexes
at rrnAP3 (3, 8, 10). In addition, CarD is localized to promoter-bound RNAP holoenzymes
throughout the genome (4). These studies suggest that CarD may in fact be a general
component of the transcription initiation machinery in mycobacteria and that its
essential role is enabling the mycobacterial RNAP to efﬁciently form open complexes at
all promoters in the genome. In particular, changes in the afﬁnity of CarD for the RNAP
could result in a global dysregulation of gene expression. Alternatively, phenotypes of
CarD mutants may result from the deregulation of a speciﬁc subset of genes differen-
tially regulated by CarD. It should also be noted that, despite the presence at all
promoters, at this point CarD activity has only been evaluated at mycobacterial rRNA
promoters and consensus promoters from E. coli. Therefore, a priority of future work will
be to clarify the role of CarD in global transcription regulation.
Using multiple CarD mutants, we have also revealed a role for the CarD-RNAP interac-
tion in regulating CarD protein levels. Increasing the afﬁnity of CarD for RNAP increases the
cellular concentration of CarD without affecting carD transcript levels (Fig. 3A and B). The
effect on CarD protein concentration is proportional to the afﬁnity for RNAP and, of
the strains expressing carD from the attB site, CarDI27W has the highest afﬁnity for RNAP and
the highest concentration of CarD protein, while CarDR47E has the lowest afﬁnity for CarD
and the lowest CarD protein levels (Fig. 3A and B). These data suggest that CarD is
protected from proteolytic degradation while associated with RNAP. Since CarD is a known
target of the Clp protease in mycobacteria (11), one possibility is that Clp-mediated
degradation of CarD is more efﬁcient when CarD is not associated with RNAP. Thus, our
ﬁndings provide a mechanistic explanation for our previous observation that mycobacteria
contain a similar concentration of CarD and the housekeeping sigma factor (8) and suggest
that there may be a detrimental effect of excess, free cellular CarD.
MATERIALS AND METHODS
Bacterial two-hybrid assays. The bacterial two-hybrid assay used in this study is based upon the
demonstration that contact between a protein domain fused to the  subunit of RNA polymerase and
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a partner protein fused to the bacteriophage CI protein activates transcription of a lacZ reporter gene
under the control of a test promoter bearing an upstream  operator (15). Assays were performed as
described using E. coli FW102 F= OL2-62 reporter strain cells, which contain the test promoter placOL2-62
driving the expression of a linked lacZ gene on an F= episome (15). Plasmids used in these assays included
pBR-Mt CarD (1 to 66), which encodes residues 1 to 248 of the E. coli RNAP  subunit fused to residues
1 to 66 of M. tuberculosis CarD (6); plasmid pBR, which encodes the WT  subunit; and plasmid
pACCI-Mt 1, which encodes residues 1 to 236 of the bacteriophage CI protein fused to residues 52
to 178 of the  subunit of M. tuberculosis RNAP fused to residues 379 to 440 of the  subunit of M.
tuberculosis RNAP via two glycine residues (6). Plasmids carrying amino acid substitutions at residue I27
of M. tuberculosis CarD were introduced into pBR-CarD (1 to 66) by PCR.
FW102 F= OL2-62 were cotransformed with either the indicated pBR-Mt CarD (1 to 66) derivative and
pACCI-Mt 1 or pBR and pACCI-Mt 1. Individual transformants were selected and grown in
Luria-Bertani (LB) medium supplemented with carbenicillin (100 g/ml), chloramphenicol (25 g/ml),
and kanamycin (50 g/ml). No IPTG (isopropyl--D-thiogalactopyranoside) was present in the growth
medium. -Galactosidase assays were performed as described previously (6). Graphs in Fig. 1E depict the
-Gal activity in cells containing the indicated pBR-Mt CarD (1 to 66) derivative and pACCI-Mt 1. The
bar labeled “No CarD” in Fig. 1E depicts the -Gal activity observed in cells containing pBR and
pACCI-Mt 1.
Bacterial strains and growth conditions. (i)M. tuberculosis. All M. tuberculosis strains were derived
from the Erdman strain and were grown at 37°C in Sauton’s broth medium (0.5 g liter1 KH2PO4, 0.5 g
liter1 MgSO4, 4 g liter1 L-asparagine, 60 ml of glycerol, 0.05 g liter1 ferric ammonium citrate, 2.0 g
liter1 citric acid, 0.1 ml liter1 1% ZnSO4, 0.05% Tween 80 [pH 7.0]) or 7H10 agar medium (Difco)
supplemented with 60 l liter1 oleic acid, 5 g liter1 bovine serum albumin (BSA), 2 g liter1 dextrose,
0.003 g liter1 catalase (OADC), and 0.5% glycerol. Gene switching was used to construct strains of
mycobacteria expressing different carD alleles and to test for their viability (6, 16). Speciﬁcally, the M.
tuberculosis ΔcarD attB::tet-carD strain (described previously in reference 2) was transformed with
pMSG430Rv3583cI27F, pMSG430Rv3583cI27W, or pMSG430Rv3583cR47E (expresses M. tuberculosis CarDWT,
CarDI27F, CarDI27W, or CarDR47E, respectively, from a constitutive Pmyc1-tetO promoter, kanamycin resis-
tant) or pDB19Rv3583c (expresses CarDWT from a constitutive Pmyc1-tetO promoter, zeocin resistant). The
transformants were selected on 20 g ml1 kanamycin or 1.25 g ml1 zeocin. The carD gene from each
transformant was sequenced to conﬁrm the presence of the correct sequence. The M. tuberculosis ΔcarD
attB::tet-carD strains transformed with pDB19Rv3583cWT, pMSG430Rv3583cI27F, pMSG430Rv3583cI27W, or
pMSG430Rv3583cR47E were named mgm3080, csm230, csm231 and csm195, respectively.
(ii) M. smegmatis. All M. smegmatis strains were derived from mc2155 and were grown at 37°C in LB
medium supplemented with 0.5% dextrose, 0.5% glycerol, and 0.05% Tween 80 (broth). M. smegmatis
strains expressing HA-tagged CarDWT, CarDR25E, CarDI27F, or CarDI27W were engineered as described for
the analogous M. tuberculosis strains using pMSG430 expression plasmids and the M. smegmatis ΔcarD
attB::tet-carD strain (described previously in reference 2). The M. smegmatis ΔcarD attB::tet-carD strains
expressing C-terminal HA-tagged versions of M. tuberculosis CarDWT, M. tuberculosis CarDR25E, M. tuber-
culosis CarDI27F, or M. tuberculosis CarDI27W from a constitutive Pmyc1-tetO promoter at the attB site of M.
smegmatis ΔcarD attB::tet-carD were named mgm3090, mgm3091, csm228, and csm229, respectively.
Cell lysate. Next, 20-ml portions of exponential cultures of M. tuberculosis were lysed in 500 l of
NP-40 buffer (10 mM sodium phosphate [pH 8.0], 150 mM NaCl, and 0.25% NP-40) by bead beating three
times.
Immunoprecipitation. Lysate from M. smegmatis strains expressing HA-tagged alleles of CarD was
bound to monoclonal anti-HA–agarose (Sigma), and the complexes were eluted as previously described
(6, 7).
Western blot analysis. Protein samples were mixed with an SDS-PAGE loading buffer and run on a
4 to 12% Bis-Tris protein gel (Invitrogen). HA-tagged CarD in the immunoprecipitation experiment was
detected using a mouse monoclonal antibody (clone 10F05; Memorial Sloan-Kettering Cancer Center
Monoclonal Antibody Core Facility). To determine protein concentrations in cell lysate, CarD was
detected with a rabbit polyclonal antibody (2). RNAP- was detected with a mouse monoclonal antibody
in both experiments (clone 8RB13; Neoclone, Madison, WI). Horseradish peroxidase-conjugated second-
ary antibodies against mouse or rabbit (Perkin-Elmer) were used for detection.
Quantitative real-time PCR. RNA was prepared from 20 to 30 ml of M. tuberculosis Erdman (WT M.
tuberculosis), mgm3080 (CarDWT), csm195 (CarDR47E), csm230 (CarDI27F), and csm231 (CarDI27W) during the
exponential growth phase. 16S rRNA and carD levels were measured and normalized to sigA transcript
levels as previously described (2).
Mouse infections. Infection of mice with exponentially replicating M. tuberculosis Erdman strain (WT
M. tuberculosis), csm3080 (CarDWT), csm230 (CarDI27F), and csm231 (CarDI27W) strains and the determi-
nation of bacterial loads were performed as previously described (6, 7). All procedures involving animals
were conducted according to the National Institutes of Health (NIH) guidelines for the housing and care
of laboratory animals, and all procedures were performed in accordance with institutional regulations
after protocol review and approval by the Institutional Animal Care and Use Committee of the Wash-
ington University in St. Louis School of Medicine (protocol 20130156, analysis of mycobacterial patho-
genesis). Washington University is registered as a research facility with the U.S. Department of Agriculture
and is fully accredited by the American Association of Accreditation of Laboratory Animal Care. The
Animal Welfare Assurance documentation is on ﬁle with the Ofﬁce for Protection from Research Risks of
the NIH. All animals used in these experiments were subjected to no or minimal discomfort. All mice were
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euthanized by CO2 asphyxiation, which is approved by the American Veterinary Medical Association
Panel on Euthanasia.
Protein preparation for biochemical assays. Recombinant Mycobacterium bovis core RNAP was
puriﬁed from E. coli using a system kindly supplied by Robert Landick (17, 18) as previously described (7).
Recombinant M. bovis A, which is identical to M. tuberculosis A, was puriﬁed from E. coli and added to
the core RNAP to reconstitute the RNAP holoenzyme.
Preparation of ﬂuorescent promoter DNA fragments. The DNA template contains nucleotides
1470151 to 1470300 of the M. tuberculosis Erdman genomic DNA, which includes the rrnAP3 promoter.
Cy3-labeled promoter DNA was prepared as previously described (8).
Stopped-ﬂow ﬂuorescence assay. Stopped-ﬂow ﬂuorescence experiments were performed as
previously described (8). All experiments were performed using a ﬁnal M. bovis RNAP-A holoenzyme
concentration of 225 nM and a ﬁnal promoter DNA concentration of 10 nM. Experiments were performed
at 25°C under the following ﬁnal solution conditions: 14 mM Tris (pH 8.0), 120 mM NaCl, 10 mM MgCl2,
1 mM dithiothreitol (DTT), 0.1 mg/ml BSA, and 10% glycerol by volume. Equal volume mixing of protein
with promoter DNA was performed in a stopped-ﬂow apparatus (Applied Photophysics SX-20, total shot
volume 150 l, dead time  2 ms), so the initial protein and DNA solutions were each diluted by half in
order to reach their ﬁnal reaction concentrations. Due to slight hardware variations in different stopped-
ﬂow instruments, excitation light was provided by either a 510 nm ﬁxed-wavelength LED light source or
a 515-nm light source from an arc lamp passed through a monochromator. The difference in excitation
light had no effect on the data. In all cases emission was collected at 570 nm using a long-pass ﬁlter.
The ﬂuorescence was monitored for 20 min.
At least two traces were collected and averaged per condition. Traces were plotted as fold change
over DNA according to the formula (F  F0)/F0, where F0 is the buffer-subtracted signal for DNA alone,
and F is the buffer-subtracted signal for DNA mixed with protein. The ﬁnal point of each trace was used
as a measure of equilibrium ﬂuorescence. The fold change traces were ﬁt to a triple exponential from 0.1
to 1200 s using the ProData Viewer software from Applied Photophysics. The slowest observed rate
dominated the fractional amplitude of the ﬁts and was used as a measurement of kobs3. Conditions that
were repeated multiple times on different days were used to estimate standard errors of the mean (SEM).
An average SEM was used to estimate uncertainty for speciﬁc conditions that were only repeated
multiple times on the same day.
In vitro transcription assays. CarD proteins used in in vitro transcription assays were diluted into 1
dialysis buffer (20 mM Tris [pH 8.0], 150 mM NaCl, 1 mM 2-mercaptoethanol). For the aborted
3-nucleotide (nt) transcript assay (10), a linear fragment of dsDNA M. tuberculosis Erdman strain genomic
DNA containing nucleotides 1470151 to 1470300, which includes the M. tuberculosis rrnAP3 promoter,
was prepared by annealing and extending primers overlapping 85-bp primers (Integrated DNA Tech-
nologies, Coralville, IA). Reaction conditions were as follows: 200 nM M. bovis core RNAP, 2 M M. bovis
A, 2 M CarD or equivalent volume of buffer, 10 nM linear DNA template, 210 M GpU dinucleotide,
21 M UTP, 0.1 l [32-P]UTP, 13.25 mM Tris (pH 8.0), 59 mM NaCl, 10.12 mMMgCl2, 5% (vol/vol) glycerol,
1 mM DTT, and 0.1 mg/ml BSA (NEB) in a total volume of 20 l. M. bovis core and A were incubated for
10 min at 37°C, followed by the addition of CarD and 10 more minutes of incubation at 37°C. The DNA
template was added, and the reactions were diluted to 17.5 l, followed by incubation at 37°C for 10 min.
Reaction mixtures were initiated with addition of a 2.5 l of mixture containing GpU, UTP, and the
radiolabeled UTP, followed by incubation at 37°C. After 20 min, the reactions were stopped with 2
formamide buffer (98% [vol/vol] formamide, 5 mM EDTA) and run on a 22% urea-PAGE gel. Transcripts
were quantiﬁed using phosphorimaging and analyzed using Image Gauge software (FujiFilm).
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